[1]
C. . Zhou and S. . Liu, “Evaluation of the efficacy of MST-312, as a telomerase inhibitor, in the treatment of patients with multiple myeloma after stem cell transplantation”, Cell Mol Biol (Noisy-le-grand), vol. 67, no. 4, pp. 115–120, Jan. 2022.